Abstract |
Paraoxon in doses of one LD50 (0.426 mg/kg), eight times and eighty times LD 50 was applied s.c. to female Sprague-Dawley rats. After 3, 6, 10, 24 and 36--48 h the activities of enzymes GOT, GPT, GLDH, SDH, CPK and ChE were measured, once after i.m. antidote application of Toxogonin only, of Toxogonin + atropine and the next one after application of combination Toxogonin + atropine + Solcoseryl (low-molecular components of deproteinized blood from young calves. The values obtained showed that in spite of treatment with Toxogonin or Toxogonin + atropine the activities of the enzymes increased; this enhancement could be prevented by addition of Solcoseryl to Toxogonin + atropine. The ChE-activity after 36 h was equivalent to that of the control value. The effect of paraoxon in the initial phase of poisoning was discussed in connection with hypoxia and acidosis resulting from a respiratory insufficiency as well as the inhibition of ATPase-activity with restriction of the energy metabolism following: consequently the effect of Solcoseryl was interpreted as an activation of the disturbed energy metabolism.
|
Authors | H Hettwer, L Gandawidjaja |
Journal | Arzneimittel-Forschung
(Arzneimittelforschung)
Vol. 28
Issue 8
Pg. 1381-8
( 1978)
ISSN: 0004-4172 [Print] Germany |
Vernacular Title | Befunde an Phosphorsäureester-vergifteten Ratten nach Antidottherapie. II. Aktivitätsbestimmungen einiger Serumenzyme. |
PMID | 582404
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Enzymes
- Tissue Extracts
- Actihaemyl
- L-Lactate Dehydrogenase
- Succinate Dehydrogenase
- Aspartate Aminotransferases
- Alanine Transaminase
- Creatine Kinase
- Acetylcholinesterase
- Paraoxon
|
Topics |
- Acetylcholinesterase
(blood)
- Actihaemyl
(pharmacology)
- Alanine Transaminase
(blood)
- Animals
- Aspartate Aminotransferases
(blood)
- Creatine Kinase
(blood)
- Enzymes
(blood)
- Female
- L-Lactate Dehydrogenase
(blood)
- Lethal Dose 50
- Paraoxon
(poisoning)
- Rats
- Succinate Dehydrogenase
(blood)
- Time Factors
- Tissue Extracts
(pharmacology)
|